Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention

NCT04240834 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1220

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
Interventional Cardiology

Interventions

DRUG: Aspirin
DRUG: Ticagrelor

Sponsor

Fu Wai Hospital, Beijing, China